SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001640334-18-002253
Filing Date
2018-11-20
Accepted
2018-11-20 17:02:02
Documents
17

Document Format Files

Seq Description Document Type Size
1 FORM S-1 AMENDMENT NO. 3 inmune_s1a3.htm S-1/A 1343900
2 EX-1.1 inmune_ex11.htm EX-1.1 167385
3 EX-4.2 inmune_ex42.htm EX-4.2 48202
4 EX_5.1 inmune_ex51.htm EX-5.1 6605
5 EX-10.1 inmune_ex101.htm EX-10.1 38847
6 EX_23.2 inmune_ex232.htm EX-23.2 1488
8 inmune_correspimg4.jpg GRAPHIC 7343
9 inmune_correspimg5.jpg GRAPHIC 15249
10 inmune_correspimg1.jpg GRAPHIC 10129
11 inmune_s1img1.jpg GRAPHIC 7011
12 inmune_s1img10.jpg GRAPHIC 66249
13 inmune_s1img11.jpg GRAPHIC 109223
14 inmune_s1img12.jpg GRAPHIC 59039
15 inmune_s1img13.jpg GRAPHIC 79480
16 inmune_s1img14.jpg GRAPHIC 71910
17 inmune_s1img9.jpg GRAPHIC 56259
18 filename18.htm CORRESP 5460
  Complete submission text file 0001640334-18-002253.txt   2277997
Mailing Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037
Business Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-227122 | Film No.: 181196116
SIC: 2836 Biological Products, (No Diagnostic Substances)